← Open Payments lookup

CRYSTAL COLONE: Open Payments

NPI 1265742514 · NORCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,283 in 157 payments from 16 companies in 2025. Trend: 2023 $4,018 · 2024 $4,237 · 2025 $4,283

Food & beverage: $4,283
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc19$775
Neurocrine BioSciences, Inc.19$619
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$590
E.R. Squibb & Sons, L.L.C.19$475
ABBVIE INC.14$407
Vanda Pharmaceuticals Inc.22$405
Alkermes, Inc.12$295
Otsuka America Pharmaceutical, Inc.7$269
Teva Pharmaceuticals USA, Inc.10$160
Lundbeck LLC3$61

Products named: INGREZZA, CAPLYTA, COBENFY, VRAYLAR, FANAPT, INVEGA SUSTENNA, REXULTI, ARISTADA.

Industry payments across CA — which companies pay providers there.